USPH Logo

U.S. Physical Therapy, Inc. (USPH) 

NYSE
Market Cap
$1.46B
Sector
Healthcare
Industry
Medical—Care Facilities
Rank in Sector
175 of 776
Rank in Industry
8 of 39

Largest Insider Buys in Sector

USPH Stock Price History Chart

USPH Stock Performance

About U.S. Physical Therapy, Inc.

U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, …

Insider Activity of U.S. Physical Therapy, Inc.

Over the last 12 months, insiders at U.S. Physical Therapy, Inc. have bought $254,520 and sold $2.79M worth of U.S. Physical Therapy, Inc. stock.

On average, over the past 5 years, insiders at U.S. Physical Therapy, Inc. have bought $467,258 and sold $4.2M worth of stock each year.

Highest buying activity among insiders over the last 12 months: Gilmartin Kathleen A (director) — $254,520.

The last purchase of 2,000 shares for transaction amount of $172,180 was made by Gilmartin Kathleen A (director) on 2024‑09‑03.

List of Insider Buy and Sell Transactions, U.S. Physical Therapy, Inc.

2024-09-03Purchasedirector
2,000
0.0133%
$86.09$172,180-3.41%
2024-08-21SaleCOO
1,724
0.0114%
$82.50$142,230+0.20%
2024-05-30SaleChairman of the Board and CEO
2,900
0.0192%
$100.26$290,754-15.52%
2024-05-29SaleChairman of the Board and CEO
1,000
0.0067%
$100.13$100,130-14.99%
2024-05-28SaleChairman of the Board and CEO
1,100
0.0073%
$102.13$112,343-16.25%
2024-05-15Saledirector
2,500
0.0165%
$107.57$268,925-19.41%
2024-05-10SaleCo-Chief Operations Officer
2,500
0.0163%
$104.22$260,550-17.66%
2024-05-10SaleCOO
1,724
0.0113%
$105.46$181,813-17.66%
2024-03-13SaleChief Financial Officer
1,800
0.0119%
$107.28$193,103-10.52%
2024-03-13SaleEVP Gen'l Counsel & Secretary
2,000
0.0132%
$106.55$213,100-10.52%
2024-03-13Saledirector
400
0.0026%
$107.00$42,800-10.52%
2024-03-13Saledirector
500
0.0033%
$107.89$53,945-10.52%
2024-03-04SaleCo-Chief Operations Officer
1,500
0.0099%
$104.96$157,440-8.01%
2024-03-04SaleCOO
2,629
0.0173%
$104.39$274,441-8.01%
2024-03-04Saledirector
2,500
0.0164%
$104.26$260,650-8.01%
2023-12-13Saledirector
1,170
0.0077%
$92.26$107,944+1.86%
2023-11-15SaleCOO
1,500
0.01%
$87.39$131,085+7.59%
2023-11-10Purchasedirector
1,000
0.0067%
$82.34$82,340+14.86%
2023-08-15SaleEVP Gen'l Counsel & Secretary
1,000
0.0069%
$106.60$106,600-9.23%
2023-08-15Saledirector
240
0.0016%
$105.81$25,394-9.23%

Insider Historical Profitability

13.98%
READING CHRISTOPHER JChairman of the Board and CEO
95838
0.6357%
$96.62236+45%
HENDRICKSON CAREY PChief Financial Officer
21186
0.1405%
$96.6213<0.0001%
Gilmartin Kathleen Adirector
18904
0.1254%
$96.6280+0.51%
Trier Claytondirector
7000
0.0464%
$96.62122+34.23%
KOSBERG J LIVINGSTONdirector
155000
1.0281%
$96.6213+12.2%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
BlackRock$259.85M15.282.3M-0.69%-$1.8M0.01
KAYNE ANDERSON INVESTMENT MANAGEMENT LLC$149.43M8.791.32M-3.06%-$4.72M0.35
Morgan Stanley$128.67M7.571.14M+2.08%+$2.62M0.01
The Vanguard Group$121.06M7.121.07M+0.96%+$1.15M<0.01
T Rowe Price Investment Management Inc$87.25M5.13773,008+1.54%+$1.33M0.05
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.